A Pilot Study of Multi-Beam Intensity-Modulated Radiation Therapy for Node-Positive Breast Cancer Requiring Treatment of the Internal Mammary Lymph Nodes
[Protocol 10-025] |
Ho, Alice |
|
A Phase I Study of Veliparib Given with Radiation Therapy to the Chest Wall and Lymph Nodes in Patients with Inflammatory or Recurrent Breast Cancer
[Protocol 12-215] |
Ho, Alice |
|
A Phase II Study of KW-0761 or Standard Therapy in Patients with Previously Treated Adult T-Cell Leukemia-Lymphoma
[Protocol 12-251] |
Horwitz, Steven |
|
A Phase II Study of MLN8237 in Relapsed or Refractory Peripheral T-Cell Non-Hodgkin Lymphoma
[Protocol 12-096] |
Horwitz, Steven |
|
A Study of Physician Communication Skills to Promote Patients' Transition to Survivorship
[Protocol 11-180] |
Horwitz, Steven |
|
PDX-017: A Phase III Study of Pralatrexate Versus Observation in Patients with Peripheral T-Cell Lymphoma Following Initial Chemotherapy
[Protocol 10-212] |
Horwitz, Steven |
|
A Phase I Study of IPI-145 in Patients with Advanced Hematologic Cancers
[Protocol 12-088] |
Horwitz, Steven |
- Hematology
- Leukemia
- Lymphoma
|
A Phase II Study of Brentuximab Vedotin in Relapsed or Refractory CD30-positive Non-Hodgkin Lymphoma
[Protocol 12-035] |
Horwitz, Steven |
|
A Phase IB/IIA Study of Romidepsin plus Lenalidomide in Adults with Relapsed or Refractory Lymphoma and Myeloma
[Protocol 12-170] |
Horwitz, Steven |
|
A Phase II Trial of HLA Haploidentical Natural Killer Cell Infusion for Treatment of Relapsed or Persistent Leukemia Following Allogeneic Hematopoietic Stem Cell Transplant
[Protocol 07-035] |
Hsu, Katharine |
- Blood & Marrow Stem Cell Transplantation
- Blood and Marrow Transplantation
- Hematology
- Leukemia
|
A Phase II Trial of Chemotherapy Plus Cetuximab Followed by Surgery in Patients with Locally Advanced Thymoma
[Protocol 09-038] |
Huang, James |
|
A Phase II Study of Docosahexaenoic Acid (DHA) in Survivors of Triple-Negative Breast Cancer
[Protocol 12-267] |
Hudis, Clifford |
- Breast Cancer
- Survivorship
|
A Phase I Study of ABT-888 with Carboplatin and Paclitaxel in Patients with Solid Tumors Who Have Liver or Kidney Problems
[Protocol 11-118] |
Hyman, David |
|
A Phase I Study of LY3023414 in Patients with Advanced Cancer
[Protocol 12-286] |
Hyman, David |
|
A Phase II Study of Vemurafenib in Patients with BRAF V600 Mutation-Positive Cancers
[Protocol 12-131] |
Hyman, David |
- Hematology
- Hematologic Disorders
- Multiple Myeloma
|
A Phase II Study of MLN8237 in Patients with Recurrent or Persistent Uterine Leiomyosarcoma
[Protocol 12-164] |
Hyman, David |
- Endometrial and other Uterine Cancers
- Leiomyosarcoma
- Uterine Cancer
- Leiomyosarcoma
- Sarcomas
- Leiomyosarcoma
- Soft Tissue Sarcoma
|
A Phase II Study of PET Scan-Directed Combined Modality Therapy for Esophageal Cancer
[Protocol 12-011] |
Ilson, David |
|
A Phase II Study of Afatinib (BIBW 2992) in Patients with Advanced HER2-Positive Esophagogastric Cancer Refractory to Trastuzumab
[Protocol 11-166] |
Janjigian, Yelena |
- Upper Gastrointestinal
- Esophageal Cancer
- Gastric Cancer
|
A Randomized Phase II Study of Modified Docetaxel, Cisplatin, and Fluorouracil (mDCF) Treatment versus Conventional DCF with Growth Factor Support in Patients with Unresectable or Metastatic Gastric and Gastroesophageal Junction Cancer
[Protocol 06-103] |
Janjigian, Yelena |
|
A Phase III Study of Radiation Therapy with and without Temozolomide for Symptomatic or Progressive Low-Grade Gliomas
[Protocol 11-120] |
Kaley, Thomas |
- Brain Tumors, Primary
- Pediatric Brain Tumors
|
